Approval · Notice of Compliance 3098 · 1998
TRI-CYCLEN: Notice of Compliance 3098
Issued March 5, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3098
- Date
- March 5, 1998
- Company
- Ortho Pharmaceutical Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: for the treatment of moderate acne vulgaris in females who have no known contraindications to oral contraceptive therapy
- Therapeutic class
- Oral contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRI-CYCLEN | Not yet assigned | — |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.035 MG per TAB
- NORGESTIMATE 0.18 MG per TAB
- NORGESTIMATE 0.215 MG per TAB
- NORGESTIMATE 0.25 MG per TAB